MedPath

EVOBUPIVACAINE WITH NALBUPHINE FOR SPINAL ANAESTHESIA IN LOWER LIMB ORTHOPAEDIC SURGERY

Not Applicable
Completed
Registration Number
CTRI/2018/12/016655
Lead Sponsor
niversity College of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

ASA Grade I and II patients between 18-65 years of age and height between 150-180 cm undergoing lower limb orthopaedic surgeries will be included in this study.

Exclusion Criteria

1) Contraindication to subarachnoid block.

2) Known hypersensitivity to any of the drugs used in the study.

3) Obesity with BMI > 30 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of effective analgesia (time from the subarachnoid block to the time of patientâ??s first complaint of pain with VAS â?¥3)Timepoint: 0, 5, 10, 15, 20, 25, 30, 45, 60, 75, 90, 120 min after subarachnoid block
Secondary Outcome Measures
NameTimeMethod
Quality of sensory and motor blockTimepoint: 0, 5, 10, 15, 20, 25, 30, 45, 60, 75, 90, 120 min after subarachnoid block
© Copyright 2025. All Rights Reserved by MedPath